期刊文献+

盆腔淋巴结HPV16/18DNA检测在宫颈癌的应用 被引量:1

Application of HPV16/18 DNA detection in pelvic lymph node in cervical carcinoma
下载PDF
导出
摘要 目的探讨宫颈癌患者盆腔淋巴结高危型人乳头状瘤病毒16/18(HPV16/18)DNA检出情况与宫颈癌临床病理特征的相关性,同时探讨宫颈癌原发灶和盆腔淋巴结组织中HPVDNA检出的相关性及意义。方法采用前瞻性研究方法,收集鄂州市中心医院自2011年1月至2012年6月间收治的行宫颈癌根治术患者的石蜡标本,采用聚合酶链反应(PCR)方法,检测33例宫颈癌组织及115枚盆腔淋巴结组织中HPV16/18 DNA。结果 33例宫颈癌患者中盆腔淋巴结HPV16/18阳性检出率为54.55%(18/33),其阳性检出率与临床分期、有无淋巴结转移、病理分化程度、肌层浸润深度、有无宫体及阴道侵犯有关,差异均有统计学意义(x^2值分别为9.528、5.241、10.481、7.187、3.915、7.274,均P<0.05)。宫颈癌组织HPV16/18阳性检出率为72.73%(24/33),与盆腔淋巴结HPV16/18阳性检出率进行相关分析,二者呈正相关(r=0.398,P<0.05)。淋巴结转移组与淋巴结未转移组总淋巴结个数的HPV16/18阳性检出率进行比较,差异有统计学意义(x^2=36.449,P<0.05)。结论检测盆腔淋巴结有助于发现早期隐匿性转移,HPV可以作为检测微转移的特异性标志物。 Objective To explore the correlation between detection of high-risk type human papilloma virus 16/18 (HPV16/18) DNA in pelvic lymph node in patients with cervical carcinoma and clinicopathologic features, and to investigate the correlation and clinical significance of primary cervical cancer focus and HPVDNA in pelvic lymph node. Methods With prospective study method, patients undergoing radical hysterectomy of cervical carcinoma in Ezhou Center Hospital from January 2011 to June 2012 were recruited. Polymerase chain reaction (PCR) was adopted to test cervical cancer tissues of 33 cases and HPV16/18 DNA in 115 pieces of pelvic lymph node. Results The positive detection rate of pelvic lymph node HPV16/18 in 33 cases was 54.55% (18/33), and it was correlated with clinical stage, lymph node metastasis, pathology differentiation degree, muscle layer infiltration depth, corpus and vaginal infiltration. The differences had statistical significance (χ2 value was 9. 528, 5. 241, 10. 481,7. 187, 3. 915 and 7. 274, respectively, all P 〈0.05). The positive detection rate of HPV16/18 in cervical carcinoma tissue was 72.73% (24/33), and it was positively correlated with that of pelvic lymph node HPV16/18 (r =0. 398, P 〈0.05). The positive detection rate of HPV16/18 of the total number in lymph node metastasis group and the group without lymph node metastasis was statistically different (χ2 = 36. 449, P 〈 0.05). Conclusion Detecting pelvic lymph node is helpful to detect early occult metastases, and HPV can be used as specific marker of micro transfer.
作者 雷桂兰
出处 《中国妇幼健康研究》 2013年第6期915-917,共3页 Chinese Journal of Woman and Child Health Research
关键词 盆腔淋巴结 高危型人乳头状瘤病毒 宫颈癌 微转移 pelvic lymph node high-risk type human papilloma virus cervical carcinoma micro transfer
  • 相关文献

参考文献5

二级参考文献53

  • 1邹倩,濮德敏,周利平,杜鹃,张惠萍,王忠琴,卢运萍.液基超薄细胞技术及TBS系统检测2635例宫颈涂片的临床分析[J].中国实用妇科与产科杂志,2006,22(4):268-270. 被引量:52
  • 2王彤,李亚里,张全.高危型人乳头瘤病毒检测在宫颈癌筛查中的应用价值[J].中国实用妇科与产科杂志,2006,22(6):435-437. 被引量:46
  • 3韩颖鑫,韦清.用质谱技术进行HPV定量的方法[P].中国:201010526315.2011/04/27.
  • 4Marra F, Cloutier K, Oteng B, et al. Effectiveness and cost effec- tiveness of human papillomavirus vaccine:a systematic review [ J ]. Pharmaeoeconomics, 2009,27 ( 2 ) : 127 -47.
  • 5Li N, Shi JF, Franceschi S, et al. Different cervical cancer screen- ing approaches in a Chinese multicentre study [ J]. Br J Cancer, 2009,1 O0 ( 3 ) :532-537.
  • 6Castellsagu6 X, Dlaz M, de Sanjos6 S, et al. Worldwide human pap- illomavirus etiology of cervical adenocarcinoma and it scofactors: implications for screening and prevention [ J ]. J Natl Cancer Inst, 2006,98(5) :303-315.
  • 7Szostek S, Klimek M, Zawilinska B, et al. Genotypespe cific human papillomavirus detection in cervical smears[ J]. Acta Biochim Pol, 2008,55 (4) :687-692.
  • 8Spano JP, Nareelin AG, Carcelin G. HPV and cancer [ J ]. Bull Cancer,2005,92 ( 1 ) :59-64.
  • 9Andrawiss M. Cervical cancer vacines avilable in 2007 [ J ]. Drug Discov Today,2005,10(14) :949-950.
  • 10Cuzick J, Cox T. HPV DNA testing in cervical cancer screening: from evidence to policies [ J ]. Gynecol Onco1,2006,103 ( 1 ) : 8 -11.

共引文献15

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部